Induction of apoptosis and DNA stabilisation by Viscum album L;Apoptose-induktion und DNA-stabilisierung durch Viscum album L

Forschende Komplementarmedizin und Klassische Naturheilkunde

Volumn 5, Issue 4, 1998, Pages 164-171

  Bussing A ^a,b  

^a Gemeinschaftskrankenhaus Herdecke   (Germany)

^b Krebsforschung Herdecke   (Germany)

Author keywords

Apoptosis; Chromosomal instability; DNA stabilisation; Mistletoe; Mistletoe lectins; Necrosis; Viscotoxins

Indexed keywords

EID: 2842582770     PISSN: 14247364     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Thich Nhat Hanh: Klar wie ein stiller Fluss. Leimen, Werner Kristkeiz Verlag, 1993, p 25.
2. Cohen JJ, Duke RC: Apoptosis and programmed cell death in immunity. Ann Rev Immunol 1992;10:267-293.
3. Vaux DL: Evolution of apoptosis; in Sluyser M (ed:) Apoptosis in Normal Development and Cancer. London, Taylor & Francis, 1996, pp 189-200.
4. Arends MJ, McGregor AH, Wyllie AH: Apoptosis is inversely related to necrosis and determines the growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. J Pathol 1994;144:1045-1057.
5. Green DR, Martin SJ: The killer and the executioner: How apoptosis controls malignancy. Curr Opin Immunol 1995;7:694-703.
6. Yonish-Rouach E, Choisy C, Deguin V, Greugnot C, May E: The role of p53 as a transcription factor in the induction of a apoptosis. Behring Inst Mitt 1996;97:60-71.
7. Büssing A et al. (eds): Mistletoe therapy and immunological research. Anticancer Drugs 1997;8 (suppl 1):S1-S65.
8. Gregory CD: Apoptosis in the immune system; in Sluyser M (ed): Apoptosis in Normal Development and Cancer. London, Taylor & Francis, 1996, pp 223-252.
9. Home SEM, Harrison DJ, Wyllie AH: Lymphocyte apoptosis - mechanisms and implications in disease. Immunol Rev 1994;142:141-156.
10. Majno G, Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
11. Reed JC: Mechanisms of the Bcl-2 family protein function and dysfunction in health and disease. Behring Inst Mitt 1996;97:72-100.
12. Janssen O, Scheffler A, Kabelitz D: In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis). Arzneimittelforschung/Drug Res 1993;43:122-1227.
13. Büssing A, Suzart K, Bergmann J, Pfüller U, Schietzel M, Schweizer K: Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the misteltoe lectins. Cancer Lett 1996;99:59-72.
14. Büssing A, Suzart K, Schweizer K, Schietzel M: Killing und Inflammation - Über die Apoptose-induzierende Potenz von Viscum album L.-Extrakten. Z Onkol 1996;28:2-9.
15. Büssing A: Induction of apoptosis by the mistle-toe lectins. A review on the mechanisms of cytotoxicity mediated by Viscum album L. Apoptosis 1996;1:25-32.
16. lo) by the N-acetyl-D-galactosamine-specific lectin from Viscum album L. Cell Death Differ 1998;5:231-240.
17. Büssing A, Multani AS, Pathak S, Pfüller U, Schietzel: Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations. Cancer Lett 1998;130:1-12.
18. Möckel B, Schwarz T, Zinke H, Eck J, Langer M, Lentzen H: Effects of mistletoe lectin I on human blood cell lines and peripheral blood cells. Cytotoxicity, apoptosis and induction of cytokines. Arzneimittelforschung//Drug Res. 1997;47: 1145-1151.
19. Hostanska K, Hajto T, Weber K, Fischer J, Lentzen H, Sütterlin B, Sailer R: A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apotosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes. Nat Immun 1996-1997(1998); 15:295-311.
20. Stirpe F, Sandvig K, Olsnes S, Pihl A: Action of Viscumin, a toxic lectin from mistletoe, on cells in culture. J Biol Chem 1982;257:13271-13277.
21. Endo Y, Tsurugi K, Franz H: The site of action of the A-chain of mistletoe lectin I on eukaryotic ribosomes - the RNA N-glycosidase activity of the protein. FEBS Lett 1988;231:378-380.
22. Benson SC, Olsnes C, Pihl A, Skorre J, Abraham A: On the mechanism of protein synthesis inhibition by abrin and ricin. Eur J Biochem 1975;59:573.
23. Montanaro I, Sperti S, Mattioli A, Testoni G, Stirpe F: Inhibition by ricin of protein synthesis in vitro. J Biochem 1975;146:127-131.
24. Furutani M, Kashiwagi K, Ito K, Endo Y, Igarashi K: Comparison of the modes of action of a Vero toxin (a Shiga-like toxin) from Escherichia coli, of ricin, and of sarcin. Arch Biochem Biophys 1992;293:140-146.
25. Göckeritz W, Körner IJ, Kopp J, et al: Mistletoe lectins: Comparative studies on Cytotoxicity, receptor binding and their effect on the cytosolic calcium content in human lymphocytes; in Van Driessche E, Fischer J, Beeckmans S, Bog-Hansen TC (eds): Lectins: Biology, Biochemistry, Clinical Biochemistry. Hellerup, Textop, 1994, vol 10, pp 345-354.
26. Dietrich JB, Ribéreau-Gayon G, Jung ML, Franz H, Beck JP, Anton R: Identity of the N-terminal sequences of the three A chains of mistletoe (Viscum album L.) lectins: Homology with ricin-like plant toxins and single chain ribosome-inhibiting proteins. Anticancer Drugs 1992;3: 507-511.
27. Ribéreau-Gayon G, Jung ML, Dietrich JB, Beck JP: Lectins and viscotoxins from mistletoe (Viscum album L.) extracts: Development of a bioassay of lectins; in Van Driessche E, Franz S, Beeckmans S, Pfuller U, Kallikorm A, Bog-Hansen TC (eds): Lectins: Biology, Biochemistry, Clinical Biochemistry. Hellerup, Textop, 1993, vol 8, pp 21-28.
28. Ribéreau-Gayon H, Jung ML, Beck JP, Anton R: Effect of fetal calf serum on the cytotoxic activity of mistletoe (Viscum album L.) lectins in cell culture. Phytother Res 1995;9:336-339.
29. Barbieri L, Valbonesi P, Bonora E, Gorini P, Bolognesi A, Stirpe F: Polynucleotide: adenosine glycosidase activity of ribosome-inactivating proteins: Effect on DNA, RNA and poly(A). Nucleic Acids Res 1997;25:518-522.
30. Winterfeld K, Leiner M: Zur Kenntnis des Viscotoxins. Arch Pharm 1956;289:358-364.
31. Samuelsson G: Phytochemical and pharmacological studies on Viscum album L. I. Viscotoxin, its isolation and properties. Sven Farm Tidskc 1958;62:169-190.
32. Samuelsson G: Phytochemical and pharmacological studies on Viscum album L. V. Further improvements in the isolation methods for viscotoxin. Studies on viscotoxin from Viscum album growing on Tillia cordata mill. Sven Farm Tidskc 1961;65:481-494.
33. Samulesson G: Mistletoe toxins. System Zool 1974;22:566-569.
34. Samuelsson G, Jayawardene AL: Isolation and characterization of visctoxin 1-PS from Viscum album L. ssp. austriacum (Wiesb.) Vollmann, growing on Pinus silvestris. Acta Pharm Suec 1974;11:175-184.
35. Schrader-Fischer G, Apel K: cDNA-derived identification of novel thionin precursors in Viscum album that contain highly divergent thionin domains but conserved signal and acid polypeptide domains Plant Mol Biol 1993;35:1233-1242.
36. Woynarowski JM, Konopa J: Interaction between DNA and viscotoxins. Cytotoxic basic polypeptides from Viscum album L. Hoppe-Seylers Z Physiol Chem 1980;361:1535-1545.
37. Konopa J, Woynarowski JM, Lewandowska-Gumieniak M: Isolation of viscotoxins. Cytotoxic basic polypeptides from Viscum album L. Hoppe-Seylers Z Physiol Chem 1980;361:1525-1533.
38. Urech K, Schaller, Ziska P, Giannattasio M: Comparative study on the cytotoxic effect of viscotoxin and mistletoe lectin on tumour cells in culture. Phytother Res 1995;9:49-55.
39. Monteiro J, Batliwalla F, Ostrer H, Gregersen PK: Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J Immunol 1996,156:3587-3590.
40. Akbar AN, Salmon M, Savill J, Janossy G: A possible role for bcl-2 in regulating T-cell memory - a 'balancing act' between death and survival. Immunol Today 1993;14:526-532.
41. Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadeen N, Pilling D, Pett S, Grundy JE, Janossy GJ: The significance of low bcl-2 expression by CD45R0 T cells in normal individuals and patients with acute viral infections. Exp Med 1993;178:427-438.
42. Yoshino T, Kondo E, Cao L, Takahashi K, Nomura S, Akagi T: Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral blood T and B lymphocytes. Blood 1994;83:1856-1861.
43. Acatrinei GN: Polyploide und Aneuploide in Zwiebelwurzeln unter Einfluss physiologischaktiver Substanzen des Extraktes aus der Mistel (Viscum album L.) (Russisch). Genetika 1966;4: 97-104.
44. Acatrinei GN: Changes in the mechanism of cell division induced by physiologically active substances in a plant extract (Russian) Fisol Rast 1967;14:271-275.
45. Acatrinei GN: Effect of physiologically active substances from mistletoe (Viscum album) extract on the nuclear division of onion cells, binuclear cells, synchronous and asynchronous bimitoses (Russian). Genetika 1969;5:170-174.
46. Healy KC: Telomere dynamics and telomerase activation in tumour progression: Prospects for prognosis and therapy. Oncol Res 1995;7:121-130.
47. Sharma HW, Maltese JY, Zhu X, Kaiser HE, Narayanan R: Telomeres, telomerase and cancer: Is the magic bullet real? Anticancer Res 1996;16;511-515.
48. Pathak S, Dave BJ, Gagos SH: Chromosome alterations in cancer development and apoptosis. In Vivo 1994;8;843-850.
49. Pathak S, Risin S, Brown NM, Berry KK: Telomeric association of chromosomes is an early manifestation of programmed cell death. Int J Oncol 1994;4:323-328.
50. Lane DP: Worrying about p53. Curr Biol 1992;2:581-583.
51. Kuirbitz SJ, Plunkett BS, Walsh WV, Kasten MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992;88:7491-7495.
52. Evan GI, Brown L, Whyte M, Harrington E: Apoptosis and the cell cycle. Curr Opin Cell Biol 1995;123:7-22.
53. Mertens R, Rubbert F Büssing A: Childhood acute lymphoblastic leukemia (ALL): Sister chromatid exchange (SCE) frequency and lymphocyte subpopulations during therapy. Leukemia 1995;9:501-505.
54. Büssing A, Azhari A, Ostendorp H, Lehnert A, Schweizer K: Viscum album L. extracts reduce sister chromatid exchanges in cultured peripheral blood mononuclear cells. Eur J Cancer 1994;30A:1836-1841.
55. Büssing A, Lehnert A, Schink M, Mertens R, Schweizer K: Effect of Viscum album L. on rapidly proliferating amniolic fluid cells: Sister chromatid exchange frequency and proliferation index. Arzneimittelforschung/Drug Res 1995;45:81-83.
56. Büssing A, Regnery A, Schweizer K: Effects of Viscum album L. on cyclophosphamide-treated peripheral blood mononuclear cells in vitro: Sister chromatid exchanges and activation/proliferation marker expression. Cancer Lett 1995; 94:199-205.
57. Büssing A, Jungmann H, Suzart K, Schweizer K: Suppression of sister chromatid exchange-inducing DNA lesions in cultured peripheral blood mononuclear cells by Viscum album L. J Exp Clin Cancer Res 1996;15:103-114.
58. Büssing A, Jurin M, Zarkovic N, Azhari T, Schweizer K: DNA-stabilisierende Wirkungen von Viscum album L. Sind Mistelextrakte als Adjuvans während der konventionellen Chemotherapie indiziert? Forsch Komplementärmed 1996;3:244-248.
59. Kovacs E, Hajto T, Hostanska: Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador). Eur J Cancer 1991;27:1672-1676.
60. Kovacs E, Kuehn JJ, Werner M, Hoffmann J: Effect of Iscador on DNA repair after radiation or cyclophosphamide. Correlation with IFN-γ production (abstract). Onkologie 1995;18(suppl 2): 651.
61. Kovacs E, Kuehn JJ, Werner M, Hoffmann J: Die Wirkung einer Behandlung mit Viscum album (Iscador®) auf die DNA-Reparatur der Lymphozyten bei Karzinompatienten (abstract). Forsch Komplementärmed 1996;3 (suppl 1):18.
62. Narimanov AA, Popova OI, Muraviova DD: Viscum album L. polysaccharides used to change the sensitivity of mice to γ-radiation. Radiobiologiia 1992;32:868-872.
63. Kuttan G, Kuttan R: Reduction of leukopenia in mice by 'viscum album' administration during radiation and chemotherapy. Tumori 1993;79:74-76.
64. Kuttan G, Menon LG, Kuttan R: Prevention of 20-methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador. Carcinogenesis 1996; 17:1107-1109.
65. Kuttan G, Menon LG, Anthony S, Kuttan R: Anticarcinogenic and antimetastatic activity of Iscador. Anticancer Drugs 1997;8 (suppl 1): S15-S16.
66. Beuth J: Clinical relevance of immunoactive mistletoe lectin-1. Anticancer Drugs 1997;8 (suppl 1):S53-S55.
67. Schink M: Mistletoe therapy for human cancer: The role of the natural killer cells. Anticancer Drugs 1997;8(suppl 1):S47-S51.
68. Stein GM, Stettin A, Schultze J, Berg PA: Induction of anti-mistletoe lectin antibodies in relation to different mistletoe extracts, A short review. Anticancer Drugs 1997b;8(suppl 1):S57-S59.
69. Heiny BM, Beuth J: Misteltoe extract standardized for the galactoside-specific Iectin (ML-1) induces β-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 1994;14:1339-1342.
70. Böcher E, Stumpf C, Büssing A, Schietzel M: Prospektive Bewertung der Toxizität hochdosierter Viscum album L.-Infusionen bei Patienten mit progredienten Malignomen. Z Onkol 1996; 28:97-106.
71. Büssing A, Stumpf C, Stumpf RT, Wutte H, Schietzel M: Therapiebegleitende Untersuchung immunologischer Parameter bei Tumor-Patienten nach hochdosierter intravenöser Applikation von Viscum album L.-Extrakten. Z Onkol 1996;28:54-59.
72. Vehmeyer K, Hajto T, Hostanska K, Könemann S, Löser H, Saller R, Wörmann B: Lectin-induced increase in clonogenic growth of haematopoietic progenitor cells. Eur J Haematol 1998;60:16-20.
73. Stettin A, Schultze JL, Stechemesser E, Berg PA: Anti-mistletoe-antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro. Klin Wochenschr 1990;68:896-900.
74. Ribéreau-Gayon H, Jung ML, Beck JP, Anton R: Effect of fetal calf serum on the cytotoxic activity of mistletoe (Viscum album L.) lectins in cell culture. Phytother Res 1995;9:336-339.
75. Ribéreau-Gayon G, Jung ML, Frantz M, Anton R: Modulation of the cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins. Anticancer Drugs 1997;8(suppl 1):S3-S8.
76. Drees M, Berger DP, Dengler WA, Fiebig GH: Direct cytotoxic effect of preparations used as unconventional methods in cancer therapy in human tumor xenografts in the clonogenic assay and in nude mice: in Arnold W, Köpf-Maier P, Micheel B (eds): Immunodeficient Animals. Models for Cancer Research. Contrib Oncol 1996;51:115-122.
77. Mathes H: Intraläsionale Mistelinjektionen in Lebermetastasen bei kolorektalem Karzinom und in das prìmäre Hepatozelluläre Karzinom (HCC) (abstract). Merkurstab 1997;50 (Sonderheft Juni):41.
78. Scheffler A, Mast H, Fischer S, Metelmann HR: Komplette Remission eines Mundhöhlenkarzinoms nach alleiniger Mistelbehandlung; in Scheer R, Becker H, Berg PA (Hrsg): Grundlagen der Misteltherapie. Akueller Stand der Forschung und klinische Anwendung. Stuttgart, Hippokrates, 1996, pp 453-464.
79. Stumpf C, Ramirez-Martinez S, Becher A, Stein GM, Büssing A, Schietzel M: Intratumorale Mistelapplikation bei stenosierendem Rezidiv eines Cardia-Carcinoms. Erfahrungsheilkunde 1997a; Sonderausgabe August: 509-513.
80. Salzer G: Pleura carcinosis. Cytomorphological findings with the mistletoe preparation Iscador and other pharmaceuticals. Oncology 1986;43:66-70.
81. Salzer G, Popp W: Die lokale Iscadorbehandlung der Pleurakarzinose; in Jungi WF, Senn HJ (Hrsg): Krebs und Alternativmedizin II. Heidelberg, Springer, 1990, pp 70-83.
82. Stumpf C, Schietzel M: Intrapleurale Instillation eines Extraktes aus Viscum album [L.] zur Behandlung maligner Pleuraergüsse. Tumordiagn Ther 1994;15:57-62.
83. Stumpf C, Büssing A: Stimulation of antitumor immunity by intrapleural instillation of a Viscum album L. extracts. Anticancer Drugs 1997;8 (suppl 1):S23-S26.
84. Büssing A, Ostendorp H, Schweizer K: In-vitro-Effekte von Viscum album [L.]-Präparationen auf kultivierte Leukämie-Zellen und mononukleäre Zellen des peripheren Blutes. Tumordiagn Ther 1995;16:49-53.